What is Protein Sequencing Market Scope?
Protein sequencing refers to the process of deciding the amino acid sequence of all or part of proteins or peptides. There are two direct methods of protein sequencing such as mass spectrometry and Edman degradation in that mass spectrometry is widely used for protein sequencing. Increasing demand for protein biomarkers in the drug development process is trending in the protein sequencing market.
The Protein Sequencing market study is being classified by Type (Reagents & Consumables, Instrument, Analysis Products, Protein Sequencing Service and Others), by Application (Biotherapeutics and Genetic Engineering) and major geographies with country level break-up.
Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Protein Sequencing market throughout the predicted period.
Agilent Technologies (United States), Thermo Fisher Scientific, Inc. (United States), SGS S.A. (Switzerland), Shimadzu Corporation (Japan), Waters Corporation (United States), Charles River Laboratories (United States), Bioinformatics Solutions (Canada), Proteome Factory (Germany) and Rapid Novor (Canada) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Selvita (Poland).
Segmentation Analysis
Analyst at AMA have segmented the market study of Global Protein Sequencing market by Type, Application and Region.
On the basis of geography, the market of Protein Sequencing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their development strategies
In Jan 2019 , Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation acquired Core Medical Imaging, Inc.
In June 2018, Shimadzu and Protein Metrics Inc. announced a co-marketing agreement for the use of Byos with Shimadzu Q-TOF technology. The co-marketing agreement combines Shimadzu’s latest Q-TOF technology with Protein Metrics’ software, which automates biotherapeutic characterization workflows.
Influencing Market Trend
- Increasing Demand for Protein Biomarkers in the Drug Development Process
Market Drivers
- Rising drug development activities by biotechnology and pharmaceutical companies in various developing and developed regions
- Growth in the Demand for Protein Sequencing technique to Recognize Novel Peptides in Human Antibodies
Opportunities
- Technological Advancements for the Identification of Isobaric Residues in Protein Sequences
- Rising Funding for Proteomic Research by Public and Private Institutes
Restraints
- A Requirement of Expensive Equipment
Challenges
- Need for Skilled Researchers Professionals
Key Target Audience
Research and Development Organisation, End-User Industry, Potential Investors and Government Bodies
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.